Company Analysis
Sign in

Praxis Precision Medicines, Inc. (PRAX)

Nasdaq: PRAX · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2016
Full chart Alerts Compare
Grade4.8
◀ Past 3.0● Present 6.1▶ Future 4.6
4 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

28 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Praxis Precision Medicines, Inc.’s names, not what it holds today.

Patents granted
28
28 utility, 1976 to Dec 31, 2025
Granted in 2025
5
Against 5 in 2024 and 9 in 2023
Applications published
78
22 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals19
Organic fine chemistry8
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Praxis Precision Medicines, Inc. its own name
named as the applicant on its applications, in US
0 granted
68 published
Praxis Precision Medicines, Inc. its own name
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in GB)
28 granted
10 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Nov 25, 202512,479,844Ion channel modulatorsPharmaceuticalsPraxis Precision Medicines, Inc.
Sep 2, 202512,404,297Salts and crystal forms of GABA-A positive allosteric modulatorPharmaceuticalsPraxis Precision Medicines, Inc.
Jul 1, 202512,344,615Substituted pyridines as ion channel modulatorsOrganic fine chemistryPraxis Precision Medicines, Inc.
Jun 10, 202512,325,7113-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an ion channel modulatorPharmaceuticalsPraxis Precision Medicines, Inc.
Mar 25, 202512,259,378Dynamic clamps and methods of use thereofPharmaceuticalsPraxis Precision Medicines, Inc.
Nov 19, 202412,145,939Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulatorsOrganic fine chemistryPraxis Precision Medicines, Inc.
Sep 3, 202412,077,502Formulations of T-type calcium channel modulators and methods of use thereofPharmaceuticalsPraxis Precision Medicines, Inc.
Jul 9, 202412,030,881Ion channel modulatorsOrganic fine chemistryPraxis Precision Medicines, Inc.
Mar 5, 202411,918,571Compounds and their methods of usePharmaceuticalsPraxis Precision Medicines, Inc.
Jan 9, 202411,866,439Ion channel modulatorsPharmaceuticalsPraxis Precision Medicines, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 25, 20252025/0389712DYNAMIC CLAMPS AND METHODS OF USE THEREOFAnalysis of biological materialsPraxis Precision Medicines, Inc.
Dec 25, 20252025/0387382METHODS OF TREATING ESSENTIAL TREMORPharmaceuticalsPraxis Precision Medicines, Inc.
Dec 11, 20252025/0376475ION CHANNEL MODULATORSPharmaceuticalsPraxis Precision Medicines, Inc.
Dec 11, 20252025/0375380HIGH STRENGTH SINGLE UNIT DOSE FORMULATIONS AND METHODS OF USE THEREOFPharmaceuticalsPraxis Precision Medicines, Inc.
Nov 27, 20252025/0360117KCNT1 INHIBITORS COMPRISING AN ISOXAZOLE OR OXADIAZOLE CORE AND METHODS OF USEPharmaceuticalsPraxis Precision Medicines, Inc.
Nov 13, 20252025/0346576KCNT1 INHIBITORS COMPRISING A PYRAZOLE CORE AND METHODS OF USEOrganic fine chemistryPraxis Precision Medicines, Inc.
Nov 13, 20252025/0345345METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERSPharmaceuticalsPraxis Precision Medicines, Inc.
Oct 9, 20252025/0312338TREATMENT OF NEUROLOGICAL DISORDERSPharmaceuticalsPraxis Precision Medicines, Inc.
Sep 25, 20252025/0295646METHODS OF USE OF T-TYPE CALCIUM CHANNEL MODULATORSPharmaceuticalsPraxis Precision Medicines, Inc.
Sep 18, 20252025/0288570TREATMENT OF NEUROLOGICAL DISORDERSPharmaceuticalsPraxis Precision Medicines, Inc.
What it applied for, 2024 to 2025: Pharmaceuticals 22 · Organic fine chemistry 8 · Analysis of biological materials 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton PRAX · research, not advice